Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexalin Technology (NXL) EBIT (2022 - 2025)

Historic EBIT for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to -$2.3 million.

  • Nexalin Technology's EBIT rose 649.33% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.9 million, marking a year-over-year decrease of 3612.37%. This contributed to the annual value of -$7.8 million for FY2024, which is 3613.49% down from last year.
  • Nexalin Technology's EBIT amounted to -$2.3 million in Q3 2025, which was up 649.33% from -$1.6 million recorded in Q2 2025.
  • Over the past 5 years, Nexalin Technology's EBIT peaked at -$293194.0 during Q3 2022, and registered a low of -$2.9 million during Q4 2024.
  • Its 4-year average for EBIT is -$1.4 million, with a median of -$1.3 million in 2024.
  • Per our database at Business Quant, Nexalin Technology's EBIT plummeted by 72386.99% in 2023 and then surged by 649.33% in 2025.
  • Over the past 4 years, Nexalin Technology's EBIT (Quarter) stood at -$719617.0 in 2022, then tumbled by 125.74% to -$1.6 million in 2023, then plummeted by 77.0% to -$2.9 million in 2024, then grew by 18.42% to -$2.3 million in 2025.
  • Its EBIT was -$2.3 million in Q3 2025, compared to -$1.6 million in Q2 2025 and -$2.0 million in Q1 2025.